146 related articles for article (PubMed ID: 20051827)
1. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
Peng X; Li W; Tan G
Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
[TBL] [Abstract][Full Text] [Related]
2. [Role of folate receptor 1 in paclitaxel-resistance of nasopharyngeal carcinoma cells].
Li W; Tan GL; Ma YH; Peng XW; He GX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 45(12):1035-40. PubMed ID: 21215055
[TBL] [Abstract][Full Text] [Related]
3. [Differential expression of taxol resistance and taxol resistance reversal related genes in nasopharyngeal carcinoma by cDNA microarray].
Peng X; Tan G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):48-52. PubMed ID: 22349379
[TBL] [Abstract][Full Text] [Related]
4. [Effect of macrophage migration inhibitory factor (MIF) on expression of MMP-2,MMP-9,and IL-8 in nasopharyngeal carcinoma cell strains].
Li Z; Lin SX; Liang YJ; Zong YS
Ai Zheng; 2004 Feb; 23(2):130-5. PubMed ID: 14960229
[TBL] [Abstract][Full Text] [Related]
5. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
6. Inducing apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z by bcl-xL short hairpin RNA.
He CW; Liu F; Zhang YF; Liang T; Zhou KY
Ai Zheng; 2005 Jun; 24(6):646-52. PubMed ID: 15946471
[TBL] [Abstract][Full Text] [Related]
7. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells.
Wang X; Masters JR; Wong YC; Lo AK; Tsao SW
Anticancer Res; 2001; 21(1A):403-8. PubMed ID: 11299769
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of α folate receptor resulting in a reversal of taxol resistance in nasopharyngeal carcinoma.
Li W; Tan G; Ma Y; Li H; He G
Otolaryngol Head Neck Surg; 2012 Feb; 146(2):250-8. PubMed ID: 22041223
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Li Z; Ren Y; Wu QC; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Jan; 117(1):107-14. PubMed ID: 14733785
[TBL] [Abstract][Full Text] [Related]
11. Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.
Gao J; Shao Z; Yan M; Fu T; Zhang L; Yan Y
Cancer Biomark; 2018; 22(4):641-648. PubMed ID: 29914005
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells.
Sung FL; Poon TC; Hui EP; Ma BB; Liong E; To KF; Huang DP; Chan AT
In Vivo; 2005; 19(1):237-45. PubMed ID: 15796181
[TBL] [Abstract][Full Text] [Related]
13. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
Yan XD; Li M; Yuan Y; Mao N; Pan LY
Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
[TBL] [Abstract][Full Text] [Related]
14. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
[TBL] [Abstract][Full Text] [Related]
15. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
Wu MH; Chen XY; Cai KR
Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
[TBL] [Abstract][Full Text] [Related]
16. [Radiosensitization of paclitaxel combined with radiation on nasopharygneal carcinoma cells (CNE-I) in vitro].
Yuan ZY; Yang WZ; Jin J; Gao L; Liu XF; Xu GZ
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):649-52. PubMed ID: 18246791
[TBL] [Abstract][Full Text] [Related]
17. Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells.
Chi HM; Du JD; Cheng J; Mao HD
Med Sci Monit; 2019 Jan; 25():475-483. PubMed ID: 30650069
[TBL] [Abstract][Full Text] [Related]
18. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.
Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Fukumoto M; Miyazaki K
Clin Cancer Res; 2008 May; 14(10):3149-55. PubMed ID: 18483383
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
20. Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells.
Zhou L; Liu P; Chen B; Wang Y; Wang X; Chiriva Internati M; Wachtel MS; Frezza EE
Anticancer Res; 2008; 28(2A):1119-27. PubMed ID: 18507063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
